Brand Name
Lyrica
Broad Category
Analgesic Adjunct / Anticonvulsant
Class
Gabapentinoid / Glutamate modulator
MOA
Primary: binds to and blocks voltage-gated calcium channels and NMDA receptors
- diminished release of glutamate (Ca2+ blocking action)
Indications
Diabetic neuropathy
Fibromyalgia
Chronic neuropathic pain
Multimodal post op pain management (ERAS)
anticonvulsant
PO post-op pain dose (Barash)
25-50 mg BID
onset
1 hour
Duration
6-12 hours
Common SE
sedation, dizziness, blurred vision, and peripheral edema
Metabolism
Minimal
Elimination
Renal unchanged